Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemia - Wikidata - awgldk - TriplyDB

Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemia

Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemia

http://www.wikidata.org/entity/Q33660751

about

Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemia

http://www.wikidata.org/entity/Q33660751

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Quantitative assessment of Wil ...... th acute myeloblastic leukemia

@ast

Quantitative assessment of Wil ...... th acute myeloblastic leukemia

@en

type

label

Quantitative assessment of Wil ...... th acute myeloblastic leukemia

@ast

Quantitative assessment of Wil ...... th acute myeloblastic leukemia

@en

prefLabel

Quantitative assessment of Wil ...... th acute myeloblastic leukemia

@ast

Quantitative assessment of Wil ...... th acute myeloblastic leukemia

@en

P1433

Q33660751-60B69022-A4CB-4FC5-89F4-C3E6CD2E377C

P1476

Q33660751-7CDD9695-8E5F-43FE-998D-2309CFFD8C1F

P2093

Q33660751-0FBFBCB0-C9E9-45F0-89B7-C51957936455

Q33660751-261C0BA6-ABC7-4CF5-B6FE-F576FA29DCA6

Q33660751-52A759B8-2D48-4289-B76E-D09EC55F1847

Q33660751-5F4DBDAC-BD8D-44DE-8BD2-56124E3285B8

Q33660751-91041697-4479-4FD5-8BD9-A0FF6F55DCF9

Q33660751-E67B6D41-1DF9-4A34-9A4A-1DE05E0EC293

Q33660751-E6AFA3CD-6E81-4EE9-A62F-C9B21A726B83

Q33660751-F86352F4-BDC9-49F7-894D-64E5ED60F12F

P2860

Q33660751-1BAACDA2-CEAA-4209-88E8-CAE5DE380E28

Q33660751-4F3AF753-E67A-4B05-9AB1-54730696CD53

Q33660751-6A958615-B650-46E9-8247-49FEC1E9A5A3

Q33660751-82962EEE-09AD-4839-A175-930D7CDF50E1

Q33660751-8C25F8A1-8E14-4947-9DCD-44B10482924B

Q33660751-8D323BDD-DB6D-4CBE-A67A-BF7DD0C1B617

Q33660751-9E304D9B-3E2F-4247-A413-A50A18577052

Q33660751-A473D00C-F39F-4A02-867F-B9649B2C365D

Q33660751-A63BB404-D859-40BC-A0CD-74483C3BF300

Q33660751-A84E8D64-02A2-434F-B426-52CD3908DCC9

P304

Q33660751-5E332E41-C971-4359-AA8F-92CAE41972CA

P31

Q33660751-707E92B6-1590-4BA3-BE91-0F09ABAE2598

P356

Q33660751-029288E5-AEAC-4273-A09C-CC02D32E8B0C

P478

Q33660751-DA3041F8-FE41-4505-9680-4D5AEE97FD84

P50

Q33660751-E8BC528C-64CC-48F4-B69C-E4853EE87B62

P577

Q33660751-33CB5132-417B-4531-A11D-E90CAD220829

P698

Q33660751-B01725D2-348F-4DED-92BD-FAC84691BE6E

P932

Q33660751-4BCBE356-E478-44F5-9F7F-7832BF6186F8

P356

JRMS.JRMS_448_16

P1433

Journal of Research in Medical Sciences

P1476

Quantitative assessment of Wil ...... th acute myeloblastic leukemia

@en

P2093

Afsane Bahrami

http://www.w3.org/2001/XMLSchema#string

Amir Hossein Jafarian

http://www.w3.org/2001/XMLSchema#string

Hossein Ayatollahi

http://www.w3.org/2001/XMLSchema#string

Maryam Sheikhi

http://www.w3.org/2001/XMLSchema#string

Mohammad Hadi Sadeghian

http://www.w3.org/2001/XMLSchema#string

Neda Motamedirad

http://www.w3.org/2001/XMLSchema#string

Sepideh Shakeri

http://www.w3.org/2001/XMLSchema#string

Seyyede Fatemeh Shams

http://www.w3.org/2001/XMLSchema#string

P2860

The role of Wilms' tumor genes.

Overexpression of Wilms tumor 1 gene as a negative prognostic indicator in acute myeloid leukemia

Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy.

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.

Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.

Peripheral blood WT1 expression predicts relapse in AML patients undergoing allogeneic stem cell transplantation.

Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression.

WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.

The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.

P304

54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/JRMS.JRMS_448_16

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28567073

http://www.w3.org/2001/XMLSchema#string

P932

5426094

http://www.w3.org/2001/XMLSchema#string